Optimizing the use of the "state-of-the-art" performance criteria

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 6, 2015, Pages 887-891

  Haeckel, Rainer ^a   Wosniok, Werner ^b   Streichert, Thomas ^c  

^a KLINIKUM BREMEN MITTE   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

biological variation; permissible uncertainty; reference intervals

Indexed keywords

CLINICAL CHEMISTRY; CONFERENCE PAPER; LABORATORY; MAXIMUM PERMISSIBLE DOSE; MEASUREMENT; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; REFERENCE VALUE; UNCERTAINTY; BLOOD; DIAGNOSTIC PROCEDURE; HUMAN; OBSERVER VARIATION; STANDARDS;

PROSTATE SPECIFIC ANTIGEN;

CLINICAL LABORATORY TECHNIQUES; HUMANS; OBSERVER VARIATION; PROSTATE-SPECIFIC ANTIGEN; REFERENCE VALUES; UNCERTAINTY;

EID: 84929091801     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-1201     Document Type: Conference Paper

References (21)

1. Haeckel R, Wosniok W. A new concept to determine permissible imprecision and bias on the basis of biological variation and state-of-the-art. Clin Chem Lab Med 2011;49:623-35.
2. Haeckel R, Wosniok W, Gurr E, Peil B. Permissible limits for uncertainty of measurement in laboratory medicine. Clin Chem Lab Med 2015. doi: 10.1515/cclm-2014-0874 [Epub ahead of print 23 Jan 2015].
3. Smith SJ, Cooper GR, Myers GL, Sampson EJ. Biological variability in concentrations of serum-lipids: sources of variation among results from published studies and composite predicted values. Clin Chem 1993;39:1012-22.
4. Simundic AM, Kackov S, Miler M, Fraser CG, Hylthoft Petersen P. Terms and symbols used in studies on biological variation: the need for harmonization. Clin Chem 2015;61:1-2.
5. International Standard Medical laboratories-particular requirements for quality and competence, ISO 15189-2012.
6. Haeckel R, Wosniok W. Observed, unknown distributions of clinical chemical quantities should be considered to be lognormal: a proposal. Clin Chem Lab Med 2010;48:1393-6.
7. Ricos C, et al. Available from: www.westgard.com. Accessed 2014.
8. Richtlinie der Bundesaerztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen. Dt Aerzteb-latt 2008;105:C301-13. Available from: www.aerzteblatt.de/plus1308.
9. Erden G, Barazi AO, Tezcan G, Yildirimkaya MM. Biological variation and reference change values of CA 19-9, CEA and AFP in serum of healthy individuals. Scand J Clin Lab Invest 2008;68:212-8.
10. Söletormos G, Semjonow A, Sibley PE, Lamerz R, Hylthoft Petersen P, Albrecht W, et al. Biological variation of total prostate-specific antigen. A survey of published estimates and consequences for clinical practice. Clin Chem 2005;51:1342-51.
11. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press, 2001:1-151.
12. Deijter SW, Martin JS, McPherson RA, Lynch JH. Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation. Urology 1988;32:288-92.
13. Erden G, Özden T, Soydas A, Yildirimkaya MM. Biological variation and reference change value (RCV) of prostate specific antigen (PSA) levels in the serum of healthy young individuals. Gazi Med J 2009;20:152-6.
14. Schifman RB, Ahmann FR, Elvick A, Ahmann M, Coulis K, Brawer MK. Analytical and physiological characteristics of prostate specific antigen and prostatic phosphatase in serum compared. Clin Chem 1987;33:2086-8.
15. Gurr E, Krönig F, Golbeck A, Arzideh F. Limits for the determination of guiding values from intralaboratory data basis, demonstrated by prostate specific antigen (PSA). J Lab Med 2009;33:67-70.
16. Cotlove E, Harris EK, Williams GZ. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. Clin Chem 1970;16:1028-32.
17. ISO (International Organisation for Standardisation). ISO/IEC Guide 98-3:2008 Uncertainty of measurement. Part 3: guide to the expression of uncertainty in measurement (GUM:1995). Genf: ISO, ISBN 92-67-10188-9.
18. Haeckel R, Wosniok W, Kratochvila J, Carobene A. A pragmatic approach for permissible limits in external assessment schemes with a compromise between biological variation and the state of the art. Clin Chem Lab Med 2012;50:833-9.
19. Fuentes-Arderiu X. Variability of the biological variation. Scand J Clin Lab Invest 2002;62:561-4.
20. i). Available from: www.dgkl.de. Accessed on 10 January, 2014.
21. Aitchison J, Brown JA. The lognormal distribution. Cambridge: Cambridge University Press 1969:1-176.